NCT06284395 2024-10-02
Two Schemes Response in Multiple Myeloma
Hospital General de Mexico
Recruiting
Clinical Trials
4 trialsNCT04433156 2023-05-18
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Phase 2 Unknown
NCT05137860 2022-01-18
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Hospital General de Mexico
Phase 4 Unknown
NCT02773550 2020-01-18
Velcadito
Basque Health Service
Phase 4 Terminated